Cancer Biology and Therapy : Impact Factor & More
eISSN: 1555-8576pISSN: 1538-4047
Open AccessShare this on:
Key Metrics
CiteScore 
8.3
Eigenfactor
0.005 - 0.01
H-Index
126
Impact Factor
< 5
SJR
Q1Oncology
SNIP
0.87
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Biology and Therapy
Cancer Biology and Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS INC |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | EUR 2710 | GBP 2335 | USD 2970 |
| Publication Time | 11 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Cancer Biology and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Biology and Therapy
Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression
- 31 Dec 2026
- Cancer Biology & Therapy
ENPP3 drives ccRCC progression by cGAMP hydrolysis and STING–IFN suppression
- 31 Dec 2026
- Cancer Biology & Therapy
Molecular mechanisms and therapeutic strategies: DNA methylation in pancreatic cancer
- 31 Dec 2026
- Cancer Biology & Therapy
MBD2 suppresses SFRP1 expression and promotes colorectal cancer development by blocking MED19 binding to its methylated promoter
- 31 Dec 2026
- Cancer Biology & Therapy
Prolonged intratumoral treatment with TLR7/8 agonist R848 regulates the tumor immune microenvironment resulting in enhanced antitumor activity
- 31 Dec 2026
- Cancer Biology & Therapy
Parthenolide inhibits the progression of intrahepatic cholangiocarcinoma by promoting ferroptosis through inhibiting UBD
- 31 Dec 2026
- Cancer Biology & Therapy
Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression
- 31 Dec 2026
- Cancer Biology & Therapy
ENPP3 drives ccRCC progression by cGAMP hydrolysis and STING–IFN suppression
- 31 Dec 2026
- Cancer Biology & Therapy
Molecular mechanisms and therapeutic strategies: DNA methylation in pancreatic cancer
- 31 Dec 2026
- Cancer Biology & Therapy
MBD2 suppresses SFRP1 expression and promotes colorectal cancer development by blocking MED19 binding to its methylated promoter
- 31 Dec 2026
- Cancer Biology & Therapy
Prolonged intratumoral treatment with TLR7/8 agonist R848 regulates the tumor immune microenvironment resulting in enhanced antitumor activity
- 31 Dec 2026
- Cancer Biology & Therapy
Parthenolide inhibits the progression of intrahepatic cholangiocarcinoma by promoting ferroptosis through inhibiting UBD
- 31 Dec 2026
- Cancer Biology & Therapy
FAQs on Cancer Biology and Therapy
How long has Cancer Biology and Therapy been actively publishing? 
What is the publishing frequency of Cancer Biology and Therapy?
How many articles did Cancer Biology and Therapy publish last year?
What is the eISSN & pISSN for Cancer Biology and Therapy?
What is Citescore for Cancer Biology and Therapy?
What is the H Index for Cancer Biology and Therapy ?
What is SNIP score for Cancer Biology and Therapy?
What is the SJR for Cancer Biology and Therapy?
Who is the publisher of Cancer Biology and Therapy?
